Dr. Lal PathLabs Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024
May 10, 2024 at 01:45 pm IST
Share
Dr. Lal PathLabs Limited announced that at its board meeting held on May 10, 2024, approved the recommendation of final dividend of INR 6 per equity share (at 60% on a face value of INR 10 each) for the financial year ended March 31, 2024 subject To Approve the Shareholders at upcoming Annual General Meeting (AGM) of the company. The record date for the purpose of payment of final dividend shall be June 10, 2024.
Dr. Lal PathLabs Limited is an India-based company that is engaged in providing diagnostic and related healthcare tests and services. The Company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests by condition, which includes allergy, diabetes, health checkups, viral infections, fever, heart diseases, hypertension, cancer, abortions, anemia, arthritis, breast cancer, diphtheria, disorder of the liver, disorders of bone, drugs of abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular disorder, and viral infections. The Companyâs subsidiaries include Paliwal Diagnostics Private Limited, Paliwal Medicare Private Limited, and Dr. Lal PathLabs Nepal Private Limited.
DR. LAL PATHLABS LIMITED 
